Arkolith/Insider Trading/EIGR/Form 4

Murray Christine

DirectorEiger BioPharmaceuticals, Inc. (EIGR) · full profile →Form 4 · filed Jan 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2022Sell(S)5K$1.22$6K11K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML